Katherine Grubaugh

Alloy Ventures, Inc. is an independent Venture Capital firm founded in 1984 by Craig C. Taylor, John F. Shoch and Tony Di Bona. The firm is headquartered in Palo Alto, California.

Ferrostaal GmbH provides industrial services, including industrial machinery supplies and general contracting services for plant construction. The company was founded in 1930 and is headquartered in Essen, Germany.

UOP LLC operates as a supplier and technology licensor for the petroleum refining, gas processing and petrochemical production. Its products include catalysts and adsorbents. The firm offers design, commissioning, ongoing operations, and optimization services. The company was founded on June 17, 1914 and is headquartered in Des Plaines, IL.

GTI Energy provides research, development and training services for the natural gas industries. It offers research and development, program management, technical services, analytical services, consulting, commercialization, training and information services. The company was founded in April 2000 and is headquartered in Des Plaines, IL.

CommerceNet develops business forums to facilitate international business-to-business electronic trade, Its portfolio companies include Powerset, CommunityWalk and GigaLogix. The company was founded by Jay M. Tenenbaum, Michael Genesereth, and Jeff Shrager in 1994 and is headquartered in Los Altos, CA.

Big West Oil LLC purchases and transports crude oil and other petroleum products. Its refinery produces petroleum products including propane, iso-butane, gasoline, diesel fuel and wax products. The company was founded in 1996 and is headquartered in North Salt Lake, UT.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.

Lyondellbasell Co. manufactures polymers, petrochemicals, and fuels. It produces and markets polyolefin's, including propylene dioxide and derivatives. The firm supplies its products to the industries engaged in the manufacturing of construction materials, automotive parts, food packaging products, textiles, and medicines. The company is headquartered in Houston, TX.

Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA.

Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA.

Imagen Technologies, Inc. operates as a medical technology company that develops and offers devices for the prevention of diagnostic errors. The company was founded by Alexander Dresner, Robert Lindsey, Thomas Stuart Hotchkiss and Sumit Chopra in 2015 and is headquartered in New York, NY.

Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA.

Genome Medical Holding Co. operates tele genomics platform which allows genetic experts to consult with patients and physicians across the country. The firm specializes in genomics, genetics, precision medicine, medical practice, personalized medicine, genetic counseling, DNA and genome. The company was founded by Lisa J. Alderson, Robert C. Green and Randal W. Scott in 2016 and is headquartered in South San Francisco, CA.

Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA.

Encina Development Group LLC engages in the provision of technology solutions to produce renewable products from plastic waste. It offers renewable chemicals and renewable fuels. The company was founded by David A. Schwedel and is headquartered in The Woodlands, TX.

Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022.

Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.